1.
J Gen Intern Med
; 31(7): 797-802, 2016 07.
Artículo
en Inglés
| MEDLINE
| ID: mdl-27021294
2.
Infect Dis Clin North Am
; 32(2): 313-322, 2018 06.
Artículo
en Inglés
| MEDLINE
| ID: mdl-29778258
RESUMEN
In the pre-direct-acting antiviral era, hepatitis C virus (HCV) treatments were complex and largely managed by hepatologists, gastroenterologists, and infectious disease physicians. As direct-acting antivirals have driven up demand for treatment, the relative scarcity of these specialists has created a bottleneck effect, resulting in only a fraction of HCV-infected individuals offered treatment. The San Francisco Health Network is a safety net system of care. Its intervention was designed to be sustainable and scalable; with minimal time commitments for training providers, primary care-based HCV treatment increased 3-fold in a period of just over 3 years.